glp-1 drugs and lupus Are (Glucagon-Like Peptide-1) receptor agonists contraindicated in patients with lupus? Glucagon-like peptide and its receptor

"GLP-1 receptor agonists and gallbladder disease risk: insights into molecular mechanisms and clinical implications"

In addition, the activation of GLP-1R was shown to promote synaptic plasticity and axonal growth (90)

Clinical review: Treatment of pediatric obesity: A systematic review and meta-analysis of randomized trials

There was no clinical focus for this at all

Therefore, the regulation of the activity of microglia is believed to play a key role in the neuroinflammation of PD

For example, a 2024 paper in Anesthesiology noted: Is there any evidence that the risk of gastroparesis or gastric contents is altered by holding the daily or weekly dose